Aortic Arch; Aneurysm, Dissecting
4
0
1
2
Key Insights
Highlights
Success Rate
100% trial completion (above average)
Treatment Research
4 treatments under study, led by Selective Cerebral Perfusion Catheter
Research Leaders
6 sponsors active, led by Avania
Related Conditions
Often studied with 10 related conditions
Clinical Risk Assessment
Based on trial outcomes
Moderate Risk
Score: 50/100
0.0%
0 terminated out of 4 trials
100.0%
+13.4% vs benchmark
0%
0 trials in Phase 3/4
0%
0 of 2 completed with results
Key Signals
Data Visualizations
Phase Distribution
Trial Status
Trial Success Rate
Benchmark: 86.6%
Based on 2 completed trials
Clinical Trials (4)
Endovascular Treatment of Thoracic Aortic Disease
Study of the Thoraflex™ Hybrid Device for the Treatment of Aneurysm/Dissection of the Descending Thoracic Aorta
Guo's Aortic Arch Reconstruction: The First in Man Study of WeFlow-Arch Modular Embedded Branch Stent Graft System
Clinical Investigation of Clinical Safety and Performance of the SP-GRIPFLOW, Selective Cerebral Perfusion Catheter When Used for Cerebral Perfusion During Aortic Arch Repair
Research Network
Common Treatments
- Selective Cerebral Perfusion Catheter1
- Weflowach Moduler Embedded Branch Stent Graft System1
- Thoraflex Hybrid1
- Endovascular Stentgraft Implantation1
Active Sponsors
- Avania1
- Hangzhou Endonom Medtech Co., Ltd.1
- Matthew Eagleton1
- Vascutek Ltd.1
- Fuji Systems Corporation1
Top Investigators
Centre Hospitalier Universitaire. Heart, Chest and Vascular Centre, AMIENS
Massachusetts General Hospital
Related Conditions
- Aortic Dissection2
- Renal Artery Aneurysm1
- Thoracic Aortic Aneurysms1
- Superior Mesenteric Artery Aneurysm1
- Thoracoabdominal Aortic Aneurysm1